SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Grimm PD,Blasko JC,Sylvester JE, et al. 10-year biochemical control of prostate cancer with I-125 brachytherapy. Int J Radiat Oncol Biol Phys. 2001; 51: 3140.
  • 2
    Zelefsky MJ,Kuban DA,Levy LB, et al. Multi-institutional analysis of long term outcomes for stage T1-T2 prostate cancer treated with permanent seed implantation. Int J Radiat Oncol Biol Phys. 2007; 67: 327333.
  • 3
    Speight JL,Shinohara K,Pickett B, et al. Prostate volume change after radioactive seed implantation: possible benefit of improved dose volume histogram with perioperative steroid. Int J Radiat Oncol Biol Phys. 2000; 48: 14611467.
  • 4
    Bucci J,Morris WJ,Keyes M, et al. Predictive factors of urinary retention following prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2002; 53: 9198.
  • 5
    Terk MD,Stock RG,Stone NN. Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate. J Urol. 1998; 160: 13791382.
  • 6
    Keyes M,Schellenberg D,Moravan V, et al. Decline in urinary retention incidence in 805 patients after prostate brachytherapy: the effect of learning curve? Int J Radiat Oncol Biol Phys. 2006; 64: 825834.
  • 7
    Lee N,Wuu C,Brody R, et al. Factors predicting for postimplantation urinary retention after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2000; 48: 14571460.
  • 8
    Wagner TT,Nag S,Young D, et al. Early voiding dysfunction associated with prostate brachytherapy. Urol Oncol. 2000; 6: 2023.
  • 9
    Sacco DE,Daller M,Grocela JA, et al. Corticosteroid use after prostate brachytherapy reduces the risk of acute urinary retention. Br J Urol. 2003; 91: 345349.
  • 10
    Kelly K,Swindell R,Routledge J, et al. Prediction of urinary symptoms after Iodine 125 prostate brachytherapy. Clin Oncol. 2006; 18: 326332.
  • 11
    Kang SK,Chou RH,Dodge RK, et al. Acute urinary toxicity following transperineal prostate brachytherapy using a modified Quimby loading method. Int J Radiat Oncol Biol Phys. 2001; 50: 937945.
  • 12
    Chen CT,Waterman FM,Valicenti RK, et al. Dosimetric analysis of urinary morbidity following prostate brachytherapy (125-I vs 103-Pd) combined with external beam radiation therapy. Int J Cancer. 2001; 96( suppl): 8388.
  • 13
    Martens JM,Barrett WL. Intraoperative use of steroids reduces acute urinary retention in patients treated with prostate brachytherapy. Presented at the Radiological Society of North America (RSNA), Chicago, Illinois, Dec 1-6, 2002. Abstract 121.
  • 14
    Thomas MD,Cormack R,Tempany CM, et al. Identifying the predictors of actue urinary retention following MRI-guided prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2000; 47: 905908.
  • 15
    Eapen L,Kayser C,Deshaies Y, et al. Correlating the degree of needle trauma during prostate brachytherapy and the development of acute urinary toxicity. Int J Radiat Oncol Biol Phys. 2004; 59: 13921394.
  • 16
    Merrick GS,Butler WM,Dorsey AT, et al. Influence of prophylactic dexamethasone on edema following prostate brachytherapy. Tech Urol. 2000; 6: 117122.